Medtronic plc (MDT) Stock

Healthcare · Medical Devices · Member of S&P 500

Medtronic plc (MDT) closed at USD 94.23 on 2026-10-14, a change of +4.4 % over the past year, with a market capitalization of USD 122.09B.

Medtronic plc recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Medtronic plc key figures

Previous close

USD 94.23 (2026-10-14)

1-year change

+4.4 %

Market cap

USD 122.09B

Enterprise value

USD 142.05B

P/E ratio (trailing)

23.45

P/E ratio (forward)

14.89

EPS (trailing)

4.07

EPS (forward)

6.41

PEG ratio

1.69

Price to book

2.43

Revenue growth

13.7 %

Earnings growth

40.7 %

Dividend per share (trailing)

2.85

Short ratio

3.37

Employees

95,000

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Medtronic plc

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Medtronic plc and compare it with other stocks.